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Abstract	45	
Variation	in	the	human	fecal	microbiota	has	previously	been	associated	with	body	mass	index	(BMI).	46	
Although	obesity	is	a	global	health	burden,	the	accumulation	of	abdominal	visceral	fat	is	the	specific	47	
cardio-metabolic	disease	risk	factor.	Here,	we	explore	links	between	the	fecal	microbiota	and	abdominal	48	
adiposity	using	body	composition	as	measured	by	Dual	X-Ray	Absorptiometry	(DXA)	in	a	large	sample	of	49	
twins	from	the	TwinsUK	cohort,	comparing	fecal	16S	rRNA	diversity	profiles	with	six	adiposity	measures.	50	
Results	51	
We	profile	six	adiposity	measures	in	3,666	twins	and	estimate	their	heritability,	finding	novel	evidence	52	
for	strong	genetic	effects	underlying	visceral	fat	and	android:gynoid	ratio.	We	confirm	the	association	of	53	
lower	diversity	of	the	fecal	microbiome	with	obesity	and	adiposity	measures,	and	then	compare	the	54	
association	between	fecal	microbial	composition	and	the	adiposity	phenotypes	in	a	discovery	sub-55	
sample	of	twins.	We	identify	associations	between	the	relative	abundances	of	fecal	microbial	56	
operational	taxonomic	units	(OTUs)	and	abdominal	adiposity	measures.	Most	of	these	results	involve	57	
visceral	fat	associations,	with	the	strongest	associations	between	visceral	fat	and	Oscillospira	members.	58	
Using	BMI	as	a	surrogate	phenotype,	we	pursue	replication	in	independent	samples	from	three	59	
population-based	cohorts	including	American	Gut,	Flemish	Gut	Flora	Project,	and	the	extended	TwinsUK	60	
cohort.	Meta-analysis	across	the	replication	samples	indicate	that	8	OTUs	replicate	at	a	stringent	61	
threshold	across	all	cohorts,	while	49	OTUs	achieve	nominal	significance	in	at	least	one	replication	62	
sample.	Heritability	analysis	of	the	adiposity-associated	microbial	OTUs	prompted	us	to	assess	host	63	
genetic-microbe	interactions	at	obesity-associated	human	candidate	loci.	We	observe	significant	64	
associations	of	adiposity-OTU	abundances	with	host	genetic	variants	in	the	FHIT,	TDRG1	and	ELAVL4	65	
	 4	
genes,	suggesting	a	potential	role	for	host	genes	to	mediate	the	link	between	the	fecal	microbiome	and	66	
obesity.	67	
Conclusion	68	
Our	results	provide	novel	insights	into	the	role	of	the	fecal	microbiota	in	cardio-metabolic	disease	with	69	
clear	potential	for	prevention	and	novel	therapies.	70	
Keywords	71	
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Background	73	
Obesity	has	rapidly	become	a	global	public	health	problem	with	obesity-related	disease	now	one	of	the	74	
leading	 causes	 of	 preventable	 death	 worldwide[1].	 Although	 overall	 obesity	 poses	 a	 global	 health	75	
epidemic,	 it	 is	 the	accumulation	of	excess	abdominal	 fat	 that	 is	a	critical	 risk	 factor	 for	cardiovascular	76	
and	metabolic	disease[2].	Changes	in	diet	and	sedentary	lifestyle	can	partly	explain	the	rise	in	obesity,	77	
and	 family	and	twin	studies	also	show	a	genetic	 influence,	with	obesity	heritability	estimates	of	0.60-78	
0.70[3-6].	Genome-wide	association	studies	(GWAS)	have	identified	genetic	risk	factors[7-9],	but	genetic	79	
variants	detected	to	date	explain	less	than	3%	of	the	heritability	of	obesity,	with	prediction	ability	of	up	80	
to	20%,	suggesting	a	role	for	other	mechanisms[10].		81	
Recent	 insights	 show	 that	 the	 gut	microbiota	may	play	 a	 crucial	 role	 in	 obesity	 and	 cardio-metabolic	82	
disease	 risk.	 Many	 studies	 have	 linked	 different	 aspects	 of	 the	 fecal	 microbiome	 to	 obesity[11-17].	83	
However,	 in	most	 cases	 the	 causal	mechanisms	 leading	 to	 these	 associations	 are	unclear,	 although	 a	84	
number	of	theories	have	been	suggested,	including	alterations	in	energy	harvest	from	food[18]	and	an	85	
increase	in	potential	 inflammatory	microbes[19].	 	There	are	also	inconsistencies	in	the	taxa	associated	86	
with	obesity[16]		that	may	be	explained	in	part	by	study	design	differences	such	as	control	of	diet	and	87	
sequencing	platforms,	but	could	also	be	due	to	differences	 in	collective	bacterial	gene	function	rather	88	
than	the	species	community	composition[20].	Another	complicating	factor	that	varies	among	studies	is	89	
the	quantification	of	obesity.	While	most	human	studies	consider	BMI	as	the	measure	of	obesity[11,	21,	90	
22],	mouse	studies	typically	use	epididymal	fat	weight[23]	or	Dual-Energy	X-ray	Absorptiometry	(DXA)-91	
derived	measures	 of	 total	 body	 fat[18,	 24].	 BMI	 is	 an	 imprecise	measure	 of	 adiposity	 and	measures	92	
overall	mass	without	distinction	between	lean	and	fat	mass[25].	Estimates	of	visceral	fat,	however,	have	93	
stronger	 associations	 with	 obesity-related	 cardio-metabolic	 diseases,	 such	 as	 type-2	 diabetes	 and	94	
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cardiovascular	disease[26-28],	but	have	typically	been	difficult	to	measure	in	humans	and	have	yet	to	be	95	
linked	with	variation	in	the	human	fecal	microbiome.		96	
Previous	studies	have	attempted	to	tackle	heritability	of	attributes	of	the	microbiome.	Zoetendal	et	al.	97	
[29]	 found	 that	monozygotic	 twins	 had	more	 similar	microbiomes	 than	marital	 partners	 or	 unrelated	98	
individuals,	suggesting	either	a	role	for	host	genotype	in	gut	microbiome	colonisation	or	mother-to-child	99	
transmission	of	microbes.	In	addition,	a	study	of	Methanobrevibacter	carriage	concordance	rate	in	twins	100	
showed	higher	concordance	in	monozygotic	(MZ)	twins	[30].	A	recent	study	by	Goodrich	et	al.	[31]	was	101	
the	 first	 large-scale	 analysis	 to	 report	 heritability	 of	 the	 human	 fecal	 microbiota,	 with	 the	 relative	102	
abundance	of	16S	rRNA	gene	sequences	belonging	to	the	family	Christensenellaceae	showing	the	most	103	
variance	attributed	to	host	genetic	effects.	Christensenellaceae	was	also	enriched	in	abundance	in	the	104	
microbiomes	 of	 low-BMI	 individuals.	 Here,	 we	 build	 upon	 these	 findings	 to	 explore	 the	 association	105	
between	 the	 human	 fecal	 microbiome	 and	 abdominal	 adiposity,	 as	 the	 main	 risk	 factor	 for	 cardio-106	
metabolic	disease	risk.	We	obtained	DXA-based	measures	of	abdominal	adiposity,	specifically,	visceral	107	
fat	mass,	subcutaneous	fat	mass,	and	previously	reported	trunk	fat	measures	[32],	as	well	as	body	fat	108	
distribution,	in	a	larger	dataset	of	twins,	including	a	subset	of	the	twin	sample	profiled	by	Goodrich	et	al.	109	
(2016)[33]	 and	 a	 subset	 of	 the	 twin	 sample	 profiled	 by	 Jackson	 et	 al.	 [34].	We	 show	 that	 heritable	110	
components	 of	 the	 human	 fecal	 microbiome	 [31,	 33]	 are	 significantly	 associated	 with	 visceral	 fat,	111	
confirming	 the	key	 role	of	 the	microbiome	 in	cardio-metabolic	disease	 risk.	We	 further	 identify	a	 link	112	
between	fecal	microbiome	profiles,	visceral	fat	and	subcutaneous	fat	with	genetic	variants	in	candidate	113	
obesity	candidate	genes,	providing	potential	insights	into	mechanisms	to	relate	the	fecal	microbiome	to	114	
cardio-metabolic	disease	risk.	115	
	116	
	117	
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Results	118	
Measures	of	adiposity	were	obtained	from	an	unselected	sample	of	3,666	predominantly	female	twins	119	
from	the	TwinsUK	cohort	(TUK-D),	which	included	1,044	monozygotic	(MZ)	and	789	dizygotic	(DZ)	twin	120	
pairs	(average	age	63	years	(range	32-87);	96.4%	female).	Fecal	microbiome	profiles	were	available	for	121	
1,313	of	these	individuals	(496	MZ,	594	DZ	and	223	unrelated	individuals;	average	age	63	years	(range	122	
32-87);	 96.4%	 female).	 Demographics	 for	 these	 samples	 can	 be	 found	 in	 Table	 1	 and	 Supplementary	123	
Table	7.	Fecal	microbiome	profiles	included	601	previously	published	profiles	from	Goodrich	et	al.[35],	124	
an	additional	671	profiles	recently	reported	within	Jackson	et	al.[34]	and	41	additional	twin	profiles[33].		125	
All	 fecal	 samples	 underwent	 16S	 rRNA	 profiling	 (V4	 region)	 gene	 sequencing	 on	 the	 Illumina	MiSeq	126	
platform,	providing	2,135	operational	taxonomic	units	(OTUs)	at	97%	sequence	identity.		127	
Adiposity	and	Visceral	fat	heritability		128	
We	studied	six	adiposity	measures	in	total,	and	these	included	three	measures	of	abdominal	adiposity	129	
(visceral	fat	mass	(VFM),	subcutaneous	fat	mass	(SFM),	percentage	trunk	fat	(pTF)),	two	measures	of	130	
body	fat	distribution	(android:gynoid	ratio	(AGR)	and	waist-hip	ratio	(WHR)),	and	one	measure	of	overall	131	
obesity,	BMI.	Adiposity	was	estimated	using	DXA-derived	measures,	which	have	been	shown	to	be	132	
reliable	alternatives[36-39]	to	traditional	CT	and	MRI	scan-based	measures	of	adiposity.	The	majority	of	133	
these	adiposity	measures	have	been	previously	explored	in	the	TwinsUK	cohort,	however	VFM	and	AGR	134	
are	newly	obtained	phenotypes.	The	new	measure	of	VFM	was	highly	correlated	with	other	abdominal	135	
and	overall	adiposity	measures,	including	BMI	(Figure	1A).	Twin-based	heritability	analysis	of	VFM	136	
showed	evidence	of	a	significant	additive	genetic	component,	or	heritability	(h2),	contributing	to	0.70	137	
(95%	CI	=	0.58	–	0.74)	of	the	total	variance	in	VFM.	The	VFM	heritability	estimate	remained	high	after	138	
adjustment	for	BMI	(0.64,	see	Additional	File	5).	We	obtained	comparable	estimates	for	the	heritability	139	
of	SFM	(h2=0.72	(95%	CI	=	0.60	–	0.77)),	pTF	(h2=0.66	(95%	CI	=0.55–	0.77),	AGR	(h2=0.65	(95%	CI	=	0.55	140	
	 8	
–	0.76)),	BMI	(h2=0.75	(95%	CI	=	0.68	–	0.80)	and	a	slightly	lower	estimate	for	WHR	(h2=0.32	(95%	CI	=	141	
0.24	–	0.40)),	in	line	with	previous	studies[40-42]	(Figure	1B).		142	
The	twin	fecal	microbiome	and	its	heritability	143	
The	human	fecal	microbiome	in	the	dataset	of	1,313	twins	comprised	Firmicutes	as	the	most	dominant	144	
phylum	 (51%),	 followed	 by	 Bacteroidetes	 (39%)	 and	 Proteobacteria	 (4%).	 These	 estimates	 are	145	
comparable	 to	previously	published	results	 [35]	and	reflect	a	 typical	western	 fecal	microbiome.	Using	146	
twins,	we	 then	explored	evidence	 for	heritability	 in	 the	gut	microbial	profiles	 (relative	abundances	of	147	
OTUs),	extending	the	results	of	Goodrich	et	al.[35]	 in	the	larger	sample	of	1,313	twins	using	the	same	148	
methods	 for	OTU	heritability.	Altogether,	OTU	heritability	 in	 this	dataset	 ranged	between	0	and	0.42,	149	
and	the	average	estimate	over	all	OTUs	was	0.07.	The	most	heritable	microbe	was	an	OTU	classified	as	150	
Clostridum	 perfringens	 (h2=0.42	 (95%CI	 0.23-0.51))	 (Additional	 File	 4:	 Supplementary	 Table	 1).	 The	151	
family,	 Christensenellaceae	was	 the	most	 heritable	 family	 reported	 in	 Goodrich	 et	 al.[35],	 and	while	152	
OTUs	representing	Christensenella	were	not	the	top	ranked	in	this	larger	dataset,		Christensenella	OTU	153	
heritability	remained	high	with	one	OTU,	Greengenes	OTU	176318,	showing	a	heritability	of	0.31	(95%CI	154	
0.21-0.41).	The	microbial	heritability	estimates	presented	here	are	overall	consistent	with	 the	original	155	
microbial	twin-based	heritability	findings	from	Goodrich	et	al.[31],	and	with	recent	extended	heritability	156	
estimates	from	the	extended	TwinsUK	cohort[33].	For	example,	at	the	genus	level	heritability	estimates	157	
across	studies	show	a	correlation	of	0.67	between	this	TUK-D	dataset	and	Goodrich	et	al.[31]	(Additional	158	
File	 1:	 Figure	 A)	 and	 0.77	 between	 TUK-D	 and	 Goodrich	 et	 al.[33](Additional	 File	 1:	 Figure	 B).	159	
Approximately	6%	of	 the	dataset	 (122	OTUs)	had	evidence	 for	at	 least	moderate	heritability	 (h2>0.2),	160	
and	these	were	present	in	at	least	25%	of	individuals	(Additional	File	4:	Supplementary	Table	1).	161	
Fecal	microbiome	diversity	is	strongly	linked	to	obesity	and	central	adiposity	162	
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Microbial	diversity	(alpha-diversity)	in	obese	individuals	has	been	reported	to	be	lower	than	that	of	lean	163	
individuals[15,	31,	43].	Here	we	compared	estimates	of	Shannon	Diversity	for	the	subjects’	fecal	164	
microbiomes	with	all	adiposity	measures	using	a	linear	mixed	effects	model,	adjusting	for	diet	(see	165	
Methods),	age,	sex	and	family	relatedness.	As	in	previous	reports[15,	31,	43,	44],	we	observed	a	166	
significant	negative	association	between	Shannon	diversity	and	all	adiposity	phenotypes	(Figure	2,	167	
Additional	File	2).	VFM	showed	the	most	significant	association	with	alpha	diversity	(beta	=	-0.14,	se	=	168	
0.27,	P	=	4.13x10-7)	and	WHR	showed	the	least	significant	association	(beta	=	-0.05,	se=0.031,	P	=	0.097).	169	
All	measures	but	WHR	were	significantly	associated	with	diversity	and	therefore,	alpha	diversity	170	
measures	in	our	sample	are	not	only	negatively	associated	with	obesity,	but	are	also	significantly	lower	171	
in	individuals	with	greater	abdominal	adiposity	and	visceral	fat.	172	
Fecal	microbiome	profiles	associate	with	central	adiposity	across	twins	173	
We	investigated	the	association	of	each	OTU	with	all	adiposity	traits,	including	BMI,	across	individuals.	174	
Of	the	approximately	12,000	OTU-phenotype	associations	considered,	3,217	were	nominally	significant	175	
and	 149	 OTU	 results	 surpassed	 Bonferroni	 correction	 (P	 =	 3.90x10-6).	 The	 149	 significant	 microbial-176	
adiposity	associations	involved	97	unique	OTUs	(Additional	File	4:	Supplementary	Table	2),	and	these	fell	177	
within	 either	 the	 Firmicutes	 or	 Bacteroidetes	 phyla,	 and	 most	 within	 the	 Ruminococcaceae	 family.	178	
Visceral	 fat	 (VFM)	 associations	 made	 up	 the	 highest	 proportion	 of	 significant	 results	 surpassing	 the	179	
Bonferroni	threshold	(45%,	Figure	3A).	The	peak	result	was	an	OTU	classified	as	Oscillospira	(Greengenes	180	
OTU	 372146),	 which	 was	 associated	 with	 VFM	 (P	 =	 1.93x10-12).	 Ruminococcaceae	 OTUs	 featured	181	
prominently	 in	 the	 top	 significant	 results,	 along	 with	 a	 number	 of	 other	 OTUs	 within	 the	182	
Lachnospiraceae	 family.	 	 Given	 the	 importance	 of	 VFM	 and	 AGR	 in	 cardiovascular	 risk,	 we	 were	183	
interested	 to	 determine	 potential	 microbial	 markers	 of	 cardiovascular	 risk.	 OTUs	 within	Oscillospira,	184	
Lachnospira	 and	 Ruminococcus	 all	 showed	 negative	 associations	 with	 VFM	 and	 AGR,	 suggesting	 a	185	
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potential	 protective	 role	 for	 these	 bacteria	 in	 cardiovascular	 risk	 (Figure	 3,	 Additional	 File	 4:	186	
Supplementary	Table	2).	Blautia	OTUs	showed	a	positive	association	with	VFM	and	AGR	and	may	be	a	187	
microbial	marker	candidate	for	cardiovascular	risk	(Figure	3A,	Additional	File	4:	Supplementary	Table	2).	188	
These	results	support	 the	crucial	 role	of	 the	microbiome	towards	visceral	 fat	as	a	marker	of	adiposity	189	
and	cardio-metabolic	disease	risk.		190	
Due	to	 the	 large	number	of	OTUs	 in	 the	 top-ranked	association	results	belonging	 to	 the	same	genera	191	
and	 families,	 we	 also	 explored	 the	 peak	 results	 with	 respect	 to	 collapsed	 taxonomies,	 whereby	 we	192	
combined	sequences	from	OTUs	with	the	same	taxonomy.	We	first	tested	the	association	between	the	8	193	
genera,	 to	 which	 the	 97	 adiposity-significant	 OTUs	 were	 assigned,	 and	 adiposity.	 Altogether,	 11	194	
associations	pass	Bonferroni	correction	(P	=	0.001)	and	27	genus-adiposity	associations	were	nominally	195	
significant.	 These	 comprised	 6	 of	 the	 genera	 and	 included	 Blautia,	 Oscillospira,	 Lachnospira,	196	
Ruminococcus	 (within	 both	 Lachnospiraceae	 and	 Ruminococcaceae)	 and	 Clostridium.	 The	 two	 most	197	
significant	associations	were	obtained	between	Oscillospira	and	VFM	(P	=	3.29x10-07,	Additional	File	4:	198	
Supplementary	Table	3)	and	Blautia	and	VFM	(P	=	3.65x10-06).	We	considered	a	similar	approach	at	the	199	
family	 level	 where	 the	 most	 significant	 bacterial-adiposity	 association	 was	 a	 negative	 relationship	200	
between	 Christensenellaceae	 and	 VFM	 (P	 =	 1.48x10-10)	 supporting	 prior	 findings	 from	Goodrich	 et	 al	201	
[31].		202	
We	then	explored	fecal	microbiome	associations	with	obesity	within	a	subsample	of	247	MZ	twin	pairs	203	
to	 identify	 potential	 environmental	 or	 stochastic	 effects.	 	 MZ	 twins	 are	 matched	 for	 sex,	 age,	 have	204	
nearly	 identical	genomes,	and	very	similar	early	 life	environments.	Therefore,	microbiome	differences	205	
observed	within	MZ	twin	pairs	are	 likely	 to	be	a	 result	of	environmental	and	stochastic	 influences,	or	206	
effects	that	are	secondary	to	the	phenotype.	We	estimated	differences	in	fecal	OTU	relative	abundances	207	
within	247	MZ	 twin	pairs	and	compared	 these	 to	differences	 in	adiposity,	 for	each	of	 the	6	adiposity	208	
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phenotypes	 using	 a	 Pearson	 correlation.	 Although	 no	 results	 surpassed	 Bonferroni	 significance	 for	209	
multiple	testing	across	the	6	phenotypes,	potentially	in	part	due	to	the	smaller	sample	size,	many	of	the	210	
observed	 effects	 were	 consistent	 with	 those	 observed	 across	 1,313	 individuals	 (Additional	 File	 4:	211	
Supplementary	 Table	 2).	 	 The	 peak	 association	 in	MZ	 twin	 pairs	was	 observed	 between	 an	 unknown	212	
Clostridiales	OTU	(Greengenes	OTU	331113)	and	AGR	(Pearson	coefficient	=	-0.24,	P	=	9.68x10-05).	213	
We	performed	two	additional	follow-up	analyses	of	the	association	between	fecal	microbiome	OTUs	214	
and	adiposity	phenotypes.	Because	of	the	high	correlation	across	multiple	obesity	measures,	we	215	
explored	the	association	between	fecal	microbiome	OTUs	and	adiposity	measures	independent	of	BMI.	216	
Following	adjustment	for	BMI,	133	of	the	149	of	significant	associations	remained	nominally	significant	217	
with	the	same	direction	of	effect	(Additional	File	4:	Supplementary	Table	2).	Because	of	the	strong	218	
association	that	we	observed	between	alpha	diversity	and	adiposity,	we	also	wanted	to	assess	if	the	219	
strongest	adiposity-OTU	associations	were	with	OTUs	that	were	markers	of	diversity,	or	whether	these	220	
taxa	associated	with	adiposity	were	independent	of	species	richness.	To	this	end	we	repeated	the	221	
adiposity-OTU	analyses	at	the	149	significant	OTU-phenotype	associations	now	including	alpha	diversity	222	
as	a	covariate	in	the	linear	model	as	previously	described[34].	All	of	the	reported	significant	associations	223	
remained	nominally	significant	after	adjustment	for	alpha	diversity.		224	
Replication	of	microbial-obesity	associations	225	
We	pursued	replication	of	the	97	significant	OTUs	associated	with	visceral	fat	in	4,286	independent	226	
samples	from	three	additional	population-based	replication	samples,	including	samples	from	the	227	
American	Gut,	Flemish	Gut	Flora	Project	(FGFP),	and	extended	TwinsUK	cohorts.	Due	to	the	lack	of	228	
cohorts	with	both	visceral	fat	measurements	and	gut	microbiome	data	available,	BMI	was	used	as	a	229	
surrogate	phenotype	for	visceral	fat	in	these	analyses.	In	each	replication	cohort,	individuals	selected	230	
were	of	European	descent,	over	the	age	of	20,	and	had	BMI	ranging	between	18.5	and	30	units,	231	
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resulting	in	2,338	individuals	from	the	American	Gut	cohort	(USA),	917	individuals	from	the	FGFP	cohort	232	
(Belgium),	and	1,031	individuals	from	the	extended	TwinsUK	cohort	(UK)	who	were	not	included	in	the	233	
discovery	TwinsUK	sample.	To	account	for	the	difference	between	the	16S	rRNA	gene	sequences	234	
between	TwinsUK	discovery	sample	and	the	replication	datasets,	OTUs	in	each	replication	dataset	were	235	
picked	using	closed	reference	in	QIIME[45]	at	97%	using	UCLUST[46]	against	the	representative	236	
sequences	for	the	97	Bonferroni	significant	OTUs	associated	with	adiposity	measures,	to	maximize	237	
similarity	in	datasets	during	replication.	Further	processing	and	downstream	analyses	took	into	account	238	
technical	and	lifestyle	cohort-specific	covariates	to	match	as	closely	as	possible	the	discovery	sample	239	
and	account	for	differences	across	cohorts	(see	Methods).	240	
The	97	OTU-BMI	associations	were	tested	within	each	replication	sample	(Additional	File	3),	and	the	241	
results	were	combined	in	a	meta-analysis	across	the	three	replication	samples	(Additional	File	4:	242	
Supplementary	Table	4).	At	a	stringent	Bonferroni	significance	threshold	(P	=	0.05/97),	8	OTUs	robustly	243	
replicated	with	the	same	direction	of	effect	across	the	three	replication	cohorts	(Figure	3b,	Additional	244	
File	4:	Supplementary	Table	4),	excluding	results	with	evidence	for	heterogeneity.	Furthermore,	13	OTUs	245	
showed	evidence	for	association	with	BMI	that	was	stronger	in	the	meta-analysis	across	all	four	246	
population-based	cohorts,	compared	to	the	discovery	TwinsUK	sample	alone	(Additional	File	4:	247	
Supplementary	Table	4).	At	a	more	relaxed	significance	threshold	(nominal	significance	and	same	248	
direction	of	effect	in	at	least	1	cohort),	49	OTUs	showed	the	same	direction	of	effect	and	nominally	249	
significant	evidence	for	association	with	BMI	in	at	least	one	of	the	replication	samples	(Additional	File	4:	250	
Supplementary	Table	4).	The	8	OTUs	with	robust	evidence	for	replication	included	members	of	the	251	
Lachnospiraceae	and	Ruminococacceae,	while	the	49	OTUs	included	not	just	members	of	the	252	
Lachnospiraceae	and	Ruminococcaceae,	but	also	Christensenellaceae,	Clostridiales,	Bacteroidaceae	and	253	
Rikenellaceae.		254	
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Microbial	functional	alterations	in	obesity	255	
Given	the	strong	associations	observed	between	fecal	microbiome	variation	and	obesity	phenotypes,	we	256	
next	wished	to	assess	potential	functional	differences	that	may	be	the	result	of	a	fecal	microbiome	257	
dysbiosis	in	obesity.	To	this	end,	we	aimed	to	infer	KEGG	functions	of	the	fecal	microbes	by	using	258	
PICRUSt	to	predict	metagenomes	for	each	sample	based	on	the	closed-reference	16S	rRNA	gene	259	
sequences.	The	PICRUSt	analyses	resulted	in	altogether	233	KEGG	pathways	and	6,909	KEGG	260	
Orthologies	(KOs)	within	our	sample.	We	next	aimed	to	determine	the	relationship	between	the	inferred	261	
KEGG	functions	and	adiposity.		We	adjusted	the	KEGG	pathway	scores	obtained	for	each	individual	in	262	
our	sample	for	technical	covariates	(see	Methods),	and	performed	association	analysis	of	these	263	
functions	with	the	adiposity	measures	using	a	linear	mixed	effects	model	as	previously	described.	We	264	
also	assessed	KO	differential	abundance	in	high	and	low	visceral	fat	individuals	using	STAMP[47].	265	
Of	the	233	KEGG	pathway	associations	with	six	adiposity	measures,	13	associations	surpassed	266	
Bonferroni	correction	(P	=	3.6x10-5)	and	218	associations	were	significant	after	FDR	correction	(FDR	5%).	267	
Four	of	the	13	Bonferroni-significant	associations	were	with	KEGG	functions	related	to	metabolism,	as	268	
well	as	98	of	the	FDR	5%	significant	results	(Figure	4A).	Functions	within	carbohydrate	metabolism	were	269	
positively	associated	with	adiposity,	in	particular,	glyoxylate	and	dicarboxylate	metabolism,	which	had	a	270	
Bonferroni-significant	association	with	VFM	(P	=	1.19x10-06),	and	FDR	5%	significant	associations	with	271	
the	remaining	adiposity	measures.	Five	groups	within	the	glyoxylate	and	dicarboxylate	metabolism	272	
pathway	were	significantly	differentially	abundant	in	high	visceral	fat	and	low	visceral	fat	individuals	273	
(Figure	4B).	Two	of	these	5	groups	remained	significant	following	Bonferroni	correction,	and	these	were	274	
K03779	(ttdA,	Q		=	2.87x10-3)	and	K03780	(ttdB,	Q	=	1.79x10-3),	both	increased	in	subjects	with	high	275	
visceral	fat.	The	remaining	3	pathways	that	surpassed	Bonferroni	correction	were	obtained	between	pTF	276	
and	dioxin	degradation,	prenyltransferases	and	N-glycan	biosynthesis.	277	
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Host	genetic	influences	on	microbiome-obesity	associations		278	
Twin-based	 heritability	 estimates	 supported	 a	 strong	 genetic	 component	 for	 visceral	 fat	 and	 our	279	
heritability	 analyses	 of	 the	 fecal	 microbiome	 in	 this	 sample	 showed	 wide	 variability	 in	 heritability	280	
between	 fecal	 microbial	 taxa	 (0–0.42),	 with	 members	 of	 Firmicutes	 and	 Actinobacteria	 being	 most	281	
heritable.	The	average	heritability	of	the	overall	fecal	microbiome	sample	was	0.07,	while	the	average	282	
shared	environment	component	was	0.046	and	the	average	unique	environment	was	0.93.	The	peak	97	283	
Bonferroni	significant	OTUs	associated	with	abdominal	adiposity	in	our	sample	had	a	median	heritability	284	
of	0.16	and	an	average	OTU	heritability	of	0.16.	The	average	heritability	of	the	97	adiposity-associated	285	
OTUs	was	significantly	greater	than	the	overall	average	heritability	over	all	OTUs	at	0.07	(Wilcoxon	rank	286	
test,	P	=	<	2.2x10-16).	In	addition	the	average	unique	environmental	component	of	the	97	is	significantly	287	
lower	 than	 the	 overall	 average	 for	 all	 OTUs	 (0.79	 vs	 0.93,	Wilcoxon	 rank	 test,	 P	 <	 2.2x10-16).	 These	288	
estimates	suggest	host	genetics	impacts	both	the	fecal	microbiome	and	adiposity.	289	
To	 explore	 the	 hypothesis	 that	 host	 genetics	 may	 influence	 the	 observed	 microbial-adiposity	290	
associations,	we	performed	candidate	gene	analysis	comparing	host	genetic	variants	at	human	obesity	291	
candidate	loci	with	the	adiposity-associated	fecal	microbiome	profiles.	We	selected	SNPs	within	human	292	
loci	previously	associated	with	obesity	as	 reported	by	Locke	et	al.	 [8],	using	common	genetic	variants	293	
within	 97	 50-kb	 regions,	 centred	 around	 the	 peak	 BMI-associated	 GWAS	 SNP	 in	 each	 region.	 At	 a	294	
Bonferroni-corrected	P-value	threshold	(P	=	5.31x10-06)	taking	into	account	the	total	number	of	genomic	295	
regions	 and	 adiposity-OTUs	 considered,	 OTU	 associations	with	 genetic	 variants	 in	 3	 genomic	 regions	296	
surpassed	multiple	testing.	The	strongest	association	between	host	genotype	and	adiposity-associated	297	
OTUs	was	 observed	 between	 an	OTU	within	 the	 Clostridiales	 order	 (Greengenes	OTU	 181702)	 and	 a	298	
host	 genetic	 variant	within	 an	 intron	of	 the	FHIT	 gene	 (rs74331972	with	OTU	181702	P	 =	 2.49x10-06,	299	
Figure	5).	FHIT	encodes	the	fragile	histidine	triad	protein	and	is	a	tumour	suppressor	gene	that	has	been	300	
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linked	to	cancers	of	the	digestive	tract.	Although	the	most	significant	FHIT	association	was	obtained	with	301	
OTU	181702	(h2	=	0.13),	which	we	identified	as	significantly	associated	with	SFM	and	VFM	(P	=	1.18x10-302	
06	 and	 1.27x10-06	 respectively),	 the	 same	 genetic	 variant	was	 also	 associated	with	 another	 VFM-	 and	303	
SFM-associated	 OTU	 (rs74331972	 with	 OTU	 287790,	 P	 =	 5.38x10-05).	 The	 second	 ranked	 significant	304	
genetic	association	was	obtained	between	variants	near	gene	TDRG1	(peak	SNP	rs1433723,	P	=	4.32x10-305	
06)	 with	 an	 open	 reference	 unknown	 Clostridiales	 OTU	 (h2	 =	 0.14),	 which	 we	 had	 identified	 as	306	
significantly	associated	with	VFM	(P	=	4.97x10-07,	Figure	5).		The	final	significant	genetic	association	was	307	
observed	 at	 a	 variant	 in	 an	 intron	 of	 the	 gene	ELAVL4	 	 (rs2480677,	P	 =	 4.95x10-06,	 Figure	 5)	with	 an	308	
unknown	Blautia	OTU,	194733	(h2	=	0.02),	which	we	had	identified	as	significantly	associated	with	VFM	309	
(P	=	1.27x10-07),	SFM	(P	=	2.26x10-06),	and	AGR	(P	=	3.11x10-07)	in	the	peak	149	adiposity-OTU	results.	310	
When	we	considered	the	genetic-OTU	association	results	at	a	less	conservative	significance	threshold	(P	311	
=	 5x10-4),	 there	 were	 a	 total	 of	 412	 suggestive	 OTU-genetic	 associations	 located	 within	 or	 near	 48	312	
unique	genes,	including	obesity	genes	such	as	FTO,	RPTOR	and	TMEM18.	313	
Functional	characterization	of	host	genetic	variants	associated	with	adiposity-OTU	markers	in	the	gut	314	
We	 next	 focused	 on	 the	 three	 significant	 host	 genetic	 associations	 in	 FHIT,	 TDRG1	 and	 ELAVL4	 with	315	
adiposity-associated	 OTUs.	 The	 transcriptomic	 profiles	 for	 these	 genes	 from	 the	 GTEx	 resource[48]	316	
indicated	that	all	three	genes	are	expressed	in	tissues	that	form	part	of	the	gastrointestinal	tract.	FHIT	is	317	
expressed	 across	 a	 wide	 range	 of	 tissues,	 including	 stomach,	 colon	 (transverse	 and	 sigmoid),	 small	318	
intestine	 (terminal	 ileum),	 esophagus	 (muscularis	 and	 mucosa)	 and	 oesophagus-gastroesophageal	319	
junction.	TDRG1	is	expressed	at	highest	levels	in	testis,	in	multiple	brain	tissues,	as	well	as	oesophagus	320	
(mucosa),	while	ELAVL4	 is	 expressed	at	highest	 levels	 in	multiple	brain	 tissues,	 testis,	 pituitary	 gland,	321	
colon	(sigmoid	and	transverse),	pancreas,	small	intestine	(terminal	ileum),	oesophagus	(muscularis)	and	322	
oesophagus-gastroesophageal	junction.		323	
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We	next	 explored	 the	 functional	 impact	of	 the	 SNPs	 in	 these	 three	 genes	 that	we	 identified	 as	most	324	
significantly	associated	with	adiposity-related	 fecal	OTUs.	The	GTEx	expression	quantitative	 trait	 locus	325	
(eQTL)	analysis	results	indicate	that	rs1433723	in	TDRG1	is	an	eQTL	for	TDRG1	expression	specifically	in	326	
oesophagus	mucosa	 in	 the	 GTEx	 dataset.	We	 then	 tested	 the	 associations	 of	 this	 variant	 on	 TDRG1	327	
gene-expression	and	DNA	methylation	levels	 in	adipose	biopsies	available	for	542	individuals	from	the	328	
TwinsUK	cohort[49,	50].	We	found	that	rs1433723	also	is	significantly	associated	with	DNA	methylation	329	
levels	in	TDRG1	(peak	association:	rs1433723	with	TDRG1	cg10553343,	P	=	1.53x10-17;	Additional	File	4:	330	
Supplementary	Table	5),	but	not	with	gene	expression	profiles	 in	 these	samples	 in	adipose	tissue[49].	331	
The	 remaining	 two	 associated	 SNPs	 with	 adiposity-OTUs	 (rs74331972 in FHIT and rs2480677	 in	332	
ELAVL4)	were	not	associated	with	 the	corresponding	gene’s	expression	 levels	 in	GTEx	across	multiple	333	
tissues.	 However,	 both	 variants	 showed	modest	 effects	 on	 DNA	methylation	 levels	 in	 adipose	 tissue	334	
(rs74331972	on	FHIT cg15570148,	P	=	3.4x10-4;	and	rs2480677	on	ELAVL4	cg00322486,	P	=	1.4x10-3),	335	
but	not	on	gene	expression	profiles	in	adipose	tissue	in	our	dataset.	336	
	337	
Discussion	338	
Here,	in	the	largest	microbiota-obesity	study	to	date	using	detailed	adiposity	and	visceral	fat	measures,	339	
we	have	shown	that	fecal	microbial	diversity	and	specific	members	of	the	human	fecal	microbiota	are	340	
strongly	 associated	with	obesity-related	phenotypes,	 specifically	 abdominal	 adiposity.	 The	majority	of	341	
microbial	associations	were	obtained	with	visceral	fat,	a	key	metabolic	disease	risk	factor,	which	we	also	342	
show	 is	 strongly	heritable	 in	our	extended	sample	of	over	3,000	 twins.	 In	addition	 to	obtaining	novel	343	
heritability	estimates	for	visceral	fat,	we	show	that	android:gynoid	ratio	is	highly	heritable	in	this	same	344	
cohort,	and	confirm	high	heritability	estimates	for	the	remaining	adiposity	phenotypes.	Using	BMI	as	a	345	
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measure	 of	 obesity,	 we	 robustly	 replicate	 8	 obesity-associated	 fecal	 microbes	 in	 three	 independent	346	
samples	from	the	American	Gut,	FGFP,	and	extended	TwinsUK	dataset.	We	also	demonstrate	that	host	347	
genes	 have	 an	 effect	 on	 components	 of	 the	 fecal	 microbiota,	 including	 the	 97	 adiposity-associated	348	
OTUs,	although	the	mechanism	remains	unclear.	Given	the	impact	of	host	genetics	on	both	obesity	and	349	
fecal	microbes,	and	our	findings	of	strong	association	between	adiposity	and	fecal	microbiome	variation,	350	
our	 results	 therefore	 support	 the	 hypothesis	 that	 heritable	 microbes	 play	 a	 role	 in	 determining	351	
components	 of	 obesity	 relevant	 to	 cardio-metabolic	 disease	 and	 may	 be	 one	 potential	 source	352	
contributing	to	missing	heritability	in	obesity.	353	
Heritability	and	importance	of	visceral	fat		354	
Visceral	fat,	the	type	of	adipose	tissue	with	the	most	important	implications	for	metabolic	health[2]	was	355	
highly	heritable	(0.70)	and	showed	the	most	significant	associations	with	the	fecal	microbiota.	Previous	356	
studies,	for	example	from	the	Framingham[40],	Quebec[42]	and	Heritage[41]	family-based	cohorts	used	357	
CT	 scans	 to	 estimate	 visceral	 adiposity	 and	 found	heritability	 estimates	of	 visceral	 fat	 to	 be	between	358	
0.36	and	0.55,	which	 is	 lower	but	 comparable	 to	our	estimates	 in	 twins.	Given	 the	 strong	correlation	359	
between	multiple	adiposity	phenotypes,	we	sought	to	assess	if	the	high	heritability	observed	in	visceral	360	
fat	is	due	to	high	heritability	of	BMI.	Heritability	of	visceral	fat	remained	high	after	adjustment	for	BMI	361	
(0.64,	see	Additional	File	5),	suggesting	that	the	high	heritability	we	report	here	for	VFM	is	independent	362	
to	its	association	with	BMI.	363	
Several	microbiome	studies	have	linked	increased	overall	abdominal	adiposity,	for	example	using	body	364	
fat	 distribution	 measures	 such	 as	 waist-to-hip	 ratio,	 to	 fecal	 microbiome	 profiles[15,	 51].	 However,	365	
although	specific	probiotic	intake	has	been	reported	to	lower	visceral	fat	[52],	to	date	there	has	not	yet	366	
been	 a	 systematic	 comparison	 of	 visceral	 fat	 and	 variation	 in	 the	 fecal	 microbiome	 across	 human	367	
subjects.	Our	 results	are	 therefore	 the	 first,	 to	our	knowledge,	 to	 link	visceral	 fat	with	changes	 in	 the	368	
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fecal	microbiota	variation	in	humans.	The	findings	suggest	that	visceral	fat	mass	is	more	important	for	369	
differences	 in	 the	obese	microbiome,	 rather	 than	overall	body	mass.	This	 is	also	demonstrated	 in	 the	370	
recent	Clarke	et	al.	study	[53],	where	elite	rugby	union	players,	who	due	to	their	greater	muscle	mass	371	
were	defined	as	overweight	and	obese	(BMI	=	29	±	3),	had	a	more	diverse	microbiota	than	that	of	both	372	
low	BMI	and	high	BMI	controls.	We	also	report	a	novel	android:gynoid	ratio	heritability	estimate	of	0.65,	373	
higher	than	previous	family-based	estimates	of		0.43	[54].	Android:gynoid	ratio,	like	visceral	fat,	is	also	a	374	
risk	 factor	 for	 cardio-metabolic	 disease,	 and	 accordingly	 our	 results	 show	 consistent	 direction	 of	375	
association	effects	for	OTUs	associated	with	both	phenotypes.		376	
Visceral	fat	has	widespread	associations	with	the	human	fecal	microbiome	377	
Due	 to	 its	 importance	 in	cardio-metabolic	disease	 risk,	direct	measures	of	visceral	 fat	are	much	more	378	
informative	 than	 BMI	 in	 assessing	 the	metabolic	 consequences	 of	 obesity.	Most	microbiome	 obesity	379	
studies	 to	 date	 have	 used	 BMI	 as	 a	 biomarker,	 with	 some	 mouse	 studies	 using	 epididymal	 fat.	 We	380	
therefore	 present	 a	 novel	 dual	 approach,	 using	 visceral	 fat	 to	 find	 novel	metabolic	 associations	 in	 a	381	
sample	of	twins,	and	BMI	to	confirm	associations	across	independent	samples.		The	power	of	this	design	382	
was	 apparent	 in	 the	 number	 of	 peak	 associations	 observed	 with	 visceral	 fat.	 All	 of	 the	 reported	383	
adiposity-OTUs	 reported	 in	 this	 study	 were	 significantly	 associated	 with	 visceral	 fat,	 while	 only	 7	 of	384	
these	OTUs	were	significantly	associated	with	BMI,	suggesting	that	microbial	studies	that	only	use	BMI	385	
as	a	measurement	of	obesity	may	be	limited.	386	
Altogether,	 we	 identified	 97	 OTUs	 that	 were	 strongly	 significantly	 associated	 with	 the	 adiposity	387	
phenotypes,	and	all	of	these	were	significantly	associated	with	visceral	fat.	Although	the	97	OTUs	were	388	
not	 the	 most	 abundant	 OTUs	 within	 the	 gut,	 OTUs	 within	 the	 Firmicutes	 phylum	 showed	 the	 most	389	
significant	adiposity	associations,	perhaps	in	part	reflecting	the	dominant	frequency	of	Firmicutes	in	the	390	
human	gut.	However,	the	direction	of	association	differed	for	different	genera	within	the	Firmicutes.	For	391	
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example,	 Oscillospira	 OTUs	 often	 showed	 protective	 associations	 with	 VFM	 while	 Blautia	 OTUs	392	
commonly	showed	adverse	associations	that	could	be	used	as	potential	markers	of	cardiovascular	risk.	393	
Our	 findings	 also	 confirm	 the	 importance	 of	 fecal	microbiome	 diversity	 in	 obesity,	 as	we	 are	 able	 to	394	
replicate	 strong	 association	 between	 adiposity	 phenotypes	 and	 alpha	 diversity.	 Furthermore,	 the	395	
majority	of	 the	observed	97	VFM	associations	are	 independent	of	alpha	diversity	and	BMI,	suggesting	396	
that	the	OTUs	significant	in	this	analysis	are	not	just	markers	of	diversity,	but	form	real	associations	with	397	
adiposity	and	cardio-metabolic	disease	risk.		398	
To	 explore	 the	 factors	 underlying	 the	 variation	 in	 the	 97	 adiposity-associated	 OTUs	 we	 used	 twin	399	
modelling	and	determined	 that	 these	97	OTUs	showed	significantly	greater	average	heritability	 (0.16)	400	
compared	 to	 all	 OTUs	 in	 the	 larger	 dataset.	 The	 average	 shared	 environment	 component	 was	 also	401	
higher,	but	 the	average	unique	environment	 component	was	 lower	 than	 the	overall	 dataset	 average.	402	
We	therefore	infer	that	host	genetics	in	particular,	as	well	as	early	shared	environmental	factors,	play	an	403	
important	 role	 in	 the	 variation	 of	 obesity-associated	 microbes.	 However,	 although	 the	 estimate	404	
(including	measurement	error)	 is	 approximately	0.80,	 the	average	unique	environment	 component	 in	405	
the	97	OTUs	was	lower	than	the	overall	dataset	average.	This	is	consistent	with	findings	from	previous	406	
work[31]	that	environmental	factors	are	key	drivers	of	the	microbiome,	and	they	strongly	contribute	to	407	
variation	at	the	obesity-microbiome	associations.	408	
As	our	results	consisted	of	OTU	associations	within	the	same	families	and	genera	of	bacteria,	we	also	409	
explored	associations	of	adiposity	at	the	collapsed	taxonomic	level	(family	and	genus)	for	the	top	OTU	410	
associations.	Lachnospiraceae	and	Ruminococcaceae	continue	to	display	opposing	directions	of	effect	at	411	
the	 family	 level.	We	also	 see	 that	 the	heritable	 family	Christensenellaceae	 is	 strongly	associated	with	412	
visceral	 fat,	 as	previously	 reported	 for	BMI	 in	Goodrich	et	 al.[31].	 Christensenellaceae	was	previously	413	
found	to	be	protective	of	obesity	both	in	mice	and	in	human	twins	in	our	previous	work[31].	We	extend	414	
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the	findings	here,	showing	strong	protective	associations	between	Christensenellaceae	and	visceral	fat,	415	
in	 particular	 suggesting	 that	 individuals	 with	 Christensenellaceae	 have	 less	 cardiovascular	 risk	 than	416	
those	without.	Further	work	to	elucidate	the	mechanism	of	protection	is	required.	417	
Partial	replication	of	adiposity	associations	using	BMI	in	independent	cohorts	418	
We	pursued	replication	of	the	fecal	microbial	adiposity	associations	in	a	large	sample	of	4,286	Caucasian	419	
individuals	 from	 three	 population-based	 cohorts.	 Due	 to	 the	 lack	 of	 cohorts	 with	 both	 visceral	 fat	420	
measurements	and	gut	microbiome	data	available,	BMI	was	used	as	a	surrogate	measure	for	visceral	fat	421	
and	therefore	the	findings	 in	this	section	do	not	capture	strict	replication,	but	rather	validation	of	the	422	
visceral	fat	fecal	microbial	associations.	At	a	stringent	Bonferroni	threshold	8	OTUs	replicated	across	all	423	
cohorts,	 and	 at	 a	more	 relaxed	 threshold	 49	 OTUs	 replicated	 at	 nominal	 significance	 in	 at	 least	 one	424	
cohort	with	 the	 same	direction	of	 effect	 as	 in	 the	discovery	 sample.	 	 The	 replication	 results	 included	425	
OTUs	 classified	 within	 Lachnospiraceae	 and	 Ruminococacceae.	 A	 higher	 relative	 abundance	 of	426	
Firmicutes	has	previously	been	associated	with	obesity	in	some	but	not	all	studies,	and	several	of	these	427	
studies	show	an	increase	in	Firmicutes	in	obese	subjects[12,	55,	56].	For	example,	Ruminococcus	gnavus	428	
has	been	shown	to	be	significantly	enriched	in	low	microbial	gene	count	individuals	that	were	prone	to	429	
obesity	in	one	study[15].	However,	the	phylum	Firmicutes	contains	over	270	genera	with	many	different	430	
and	diverse	functions.	Because	changes	may	occur	at	finer-grained	taxonomic	resolution,	and	because	431	
the	 baseline	 abundance	 of	 different	 genera	 differs	 among	 human	 populations,	 opposing	 selection	432	
processes	 at	 different	 phylogenetic	 levels	may	 in	 part	 explain	 differing	 results	 in	 studies	 determining	433	
microbiota	 differences	 in	 obesity[57,	 58],	 including	 recent	 meta-analyses	 across	 multiple	 obesity	434	
microbiota	datasets[16,	59].	This	difference	in	directional	effects	in	genera	of	the	same	family	has	been	435	
noted	 in	 animal	 models.	 Mice	 consuming	 a	 Western	 diet	 have	 previously	 been	 reported	 to	 have	436	
increased	 levels	of	Eubacterium	dolichum[60],	while	another	 study	has	 shown	 that	mice	 consuming	a	437	
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high-fat	diet	have	decreased	 levels	of	Allobaculum	OTUs[61].	Both	of	 these	microbes	are	members	of	438	
the	Erysipelotrichaceae	family,	and	show	opposite	directions	of	effect	in	our	data.		439	
We	 observe	 a	 small	 number	 of	 robust	 associations	 across	 all	 cohorts,	 but	 over	 half	 of	 the	 findings	440	
validated	in	at	least	one	of	the	replication	cohorts.	The	reasons	for	the	partial	replication	of	our	results	441	
are	unclear	and	are	likely	in	part	to	capture	differences	in	protocols,	genetics,	geography,	lifestyle	and	442	
diet,	which	are	difficult	 to	account	 for	 in	 full	 during	 the	analysis.	 The	American	Gut	dataset	used	 the	443	
protocols	developed	for	the	Earth	Microbiome	Project[62]	which	are	largely	the	same	as	those	used	in	444	
Goodrich	et	 al.[31]	except	 that	 the	American	Gut	data	 set	 is	 filtered	 to	 remove	Gammaprotobacteria	445	
sequences	 increased	 following	 transit.	 FGFP	protocols	are	most	 similar	 to	TUK-D	and	TUK-R	however,	446	
with	 similar	 sample	 collection	methods	 and	 sequencing	 protocols.	 Analysis	 of	 the	American	Gut	 data	447	
adjusted	for	more	covariates	than	TUK-R,	TUK-D	and	FGFP,	and	the	cohort	itself	included	a	different	age	448	
range	(average	50,	21-94)	and	gender	ratio	(53%	female).	The	age	range	and	gender	ratio	of	the	FGFP	449	
cohort	was	 similar	 to	 AG	 (average	 age	 =	 51	 (21-85),	 55%	 female)	 while	 TUK-R	was	 expectedly	more	450	
similar	to	TUK-D	(average	age	=	57.3	(20-89),	80%	female).	Additionally,	the	American	Gut	samples	were	451	
primarily	from	the	United	States	(84%),	unlike	the	discovery	and	replication	TwinsUK	samples	from	the	452	
United	Kingdom,	and	the	Belgian	FGFP	samples.		The	majority	of	the	97	OTUs	show	the	same	direction	453	
of	association	in	the	TwinsUK	discovery,	TwinsUK	replication,	and	FGFP	samples,	but	this	is	not	the	case	454	
in	 the	 American	 Gut	 sample	 results	 (Additional	 File	 3).	 This	 observation	may	 partly	 reflect	 potential	455	
differences	in	OTU	associations	in	different	populations	and	geographical	locations,	specifically	between	456	
European	 and	 American	 samples.	 Previous	 studies	 have	 shown	 some	 differences	 at	 the	 OTU-level	457	
between	 countries[44,	 63].	 Additionally,	 the	 sample	 collection	 methods	 also	 differed	 between	 the	458	
European	 studies	with	 greater	 quantities	 collected	 in	 TUK-D,	 TUK-R	 and	 FGFP	 compared	 to	 swabs	 in	459	
American	 Gut,	 although	 neither	 used	 fixatives.	 These	 factors	 highlight	 the	 on-going	 difficulty	 in	460	
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replicating	OTU	level	results	between	studies	and	cohorts.	Additional	standardisation	of	both	technical	461	
and	 analytical	methods	 will	 help	 distinguish	 features	 common	 across	 populations,	 those	 sensitive	 to	462	
technical	influence,	and	those	unique	to	a	particular	region	or	group.	463	
Microbial	metabolism	is	altered	in	obese	individuals		464	
Our	findings	of	strong	association	between	particular	microbes	along	with	their	directional	effect	in	465	
obesity,	can	provide	insights	into	functional	impacts.	It	has	been	suggested	that	the	dysbiosis	of	466	
microbial	species	in	obesity	is	not	as	important	as	the	resulting	functional	dysbiosis[64].	Using	the	467	
PICRUSt	method	to	predict	metagenomes	and	functions,	we	find	an	enrichment	of	metabolism-related	468	
KEGG	functions	associated	with	adiposity,	in	particular	carbohydrate	metabolism	and	N-glycan	469	
biosynthesis.	We	see	a	strong	positive	association	between	visceral	fat	and	glyoxylate	and	dicarboxylate	470	
metabolism,	particularly	with	the	genes	ttdA	and	ttdB.	The	glyoxylate	cycle,	a	pathway	that	until	471	
recently	was	thought	to	be	absent	in	most	animals	[65],	is	able	to	metabolise	fatty-acids	into	glucose,	472	
thus	contributing	to	insulin	resistance	in	the	event	of	fatty-acid	abundance	[66].	More	recently	473	
glyoxylate	has	been	highlighted	as	a	biomarker	of	type	II	diabetes,	even	as	much	as	three	years	prior	to	474	
diagnosis	of	diabetes	[67].		Here	we	show	a	potential	mechanistic	impact	of	the	microbial	dysbiosis	475	
observed	in	individuals	with	increased	visceral	fat.	We	cannot	assess	whether	the	heritable	microbes	are	476	
driving	the	differences	observed	in	these	pathways,	however,	it	would	be	interesting	to	determine	the	477	
heritability	of	the	inferred	microbial	functions,	particularly	in	future	studies	with	metagenomic	datasets.	478	
Host	genetics	influences	the	human	fecal	microbiome	and	its	link	to	central	adiposity		479	
Our	 new	 OTU	 heritability	 estimates	 in	 this	 larger	 twin	 sample	 remain	 largely	 similar	 to	 those	 in	 the	480	
original	 Goodrich	 et	 al.[31]	 twin-based	 heritability	 analysis	 results,	 although	 peak	 heritable	OTUs	 are	481	
slightly	 different.	 Comparison	 of	 the	 heritability	 results	 at	 the	 genus	 level	 show	 that	 consistent	482	
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estimates	were	obtained	across	the	two	datasets	(r2	=	0.67,	Additional	File	1:	Figure	A),	and	these	were	483	
also	 consistent	 with	 a	 recent	 heritability	 analysis	 of	 the	 extended	 TwinsUK	 dataset[33]	 (r2	 =	 0.77,	484	
Additional	File	1:	Figure	B).	The	most	heritable	taxon	in	our	dataset	is	an	OTU	classified	as	Clostridium	485	
perfringens	(h2	=	0.42).	The	heritability	estimate	for	the	most	heritable	OTU	reported	in	the	Goodrich	et	486	
al.[31]	 study,	 OTU	 176318	 assigned	 to	 Christensenellaceae	 (original	 heritability	 estimated	 at	 0.36)	487	
remained	similar	 in	 the	extended	dataset,	with	a	new	heritability	of	0.31.	The	most	heritable	OTUs	 in	488	
our	dataset	were	relatively	frequent,	being	present	in	at	least	25%	of	individuals.	A	potential	mechanism	489	
that	 underlies	 fecal	 microbial	 heritability	 is	 the	 ability	 of	 the	 host	 genome	 to	 impact	 the	 gut	490	
environment,	 for	 example,	 by	 altering	 acidity	of	 the	 gut	or	by	host	 control	 of	miRNAs	 that	 can	enter	491	
bacterial	cells	and	affect	bacterial	growth[68].	Therefore,	the	likely	mechanism	of	microbial	heritability	492	
is	host	genetic	manipulation	of	microbes[69].		493	
The	OTUs	that	we	identified	as	significantly	associated	with	adiposity	phenotypes	displayed	significantly	494	
greater	estimates	of	heritability	compared	to	all	OTUs	profiled	in	the	gut,	and	therefore	prompted	us	to	495	
test	 if	 specific	 human	 genetic	 variants	 may	 explain	 the	 observed	 microbial	 heritability	 at	 these	 97	496	
adiposity-associated	OTUs.	To	explore	how	human	genes	could	influence	these	microbes	in	the	context	497	
of	 obesity,	 we	 pursued	 host	 genetic	 association	 analyses	 of	 the	 adiposity-associated	 OTUs	 using	 a	498	
candidate	gene	analysis	 approach	at	host	obesity	GWAS	 loci.	 The	most	 significant	 genetic	 association	499	
was	 obtained	 with	 a	 variant	 in	 the	 gene	 FHIT,	 which	 encodes	 the	 fragile	 histidine	 triad	 protein.	500	
Significantly	 reduced	 FHIT	 gene	 expression	 levels	 have	 been	 reported	 in	 cardiac	 tissue	 from	 obese	501	
compared	 to	 lean	 subjects[70].	 Although	 this genetic variant is	 not	 an	 eQTL	 itself,	 it	 does	 show	502	
moderate	evidence	 for	 genetic	 impacts	on	DNA	methylation	 levels	 in	 adipose	 tissue,	 specifically,	 at	 a	503	
CpG-site	 in	 a	 CpG-island	 shore	 in	 the	 promoter	 of	 the	 FHIT	 gene.	 Therefore,	 it	may	 have	 an	 indirect	504	
impact	 on	 FHIT	 adipose	 tissue	 gene	 expression	 in	 obesity	 through	 epigenetic	 regulation	 of	 FHIT	505	
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expression.	 FHIT	 also	 appears	 to	 act	 as	 a	 tumour	 suppressor	 in	 several	 types	 of	 cancer[71],	 and	 its	506	
abnormal	 function	 has	 been	 linked	 to	 cancers	 of	 the	 digestive	 tract[72].	 The	 FHIT-associated	 OTU	 is	507	
strongly	 associated	with	 abdominal	 adiposity	 in	 our	 data,	 including	 SFM	 and	 VFM,	 suggesting	 that	 it	508	
plays	a	role	in	cardio-metabolic	disease	risk	in	the	host.		509	
Human	 genetic	 variants	 in	 or	 near	 two	 other	 genes,	 ELAVL4	 and	 TDRG1,	 were	 also	 significantly	510	
associated	with	adiposity-OTUs.	Although	 these	genes	 currently	 lack	 a	 clear	biological	 link	 to	obesity,	511	
they	 are	 expressed	 in	 tissues	 that	 are	 part	 of	 the	 GI	 tract.	 Furthermore,	 rs1433723	 in	 TDRG1	 is	 an	512	
interesting	candidate	for	follow-up	as	it	exhibits	strong	genetic	influences	on	TDRG1	gene	expression	in	513	
parts	of	 the	GI	 tract	 (oesophagus	mucosa).	This	genetic	variant	also	 impacts	TDRG1	DNA	methylation	514	
levels	 in	adipose	tissue,	specifically	at	a	CpG-site	 in	an	 intra-genic	CpG	 island	 in	the	gene	body,	which	515	
could	 mark	 an	 alternative	 transcription	 start	 site.	 GTEx	 summary	 expression	 profiles	 of	 this	 gene	516	
correspondingly	show	exon	bias	in	expression	levels	across	different	tissues,	consistent	with	alternative	517	
transcript	usage.		518	
The	four	significantly	associated	host	genetic	variants	in	FHIT,	ELAVL4,	and	TDRG1	were	not	the	same	as	519	
the	lead	SNPs	for	each	candidate	obesity	locus	reported	in	Locke	et	al.[8],	and	are	in	low	to	moderate	LD	520	
with	 the	 corresponding	 lead	 SNPs	 (R2	 =	 0.014-0.25).	 This	 could	 be	 attributed	 to	 several	 reasons,	521	
including	sample	size	and	imputation	differences.	Compared	to	our	sample	of	1,313	twins,	the	sample	522	
size	 in	 Locke	 et	 al.[8]	 is	 over	 300,000	 individuals,	 resulting	 in	 excellent	 power	 to	 detect	 phenotypic	523	
associations	with	particular	 lead	SNPs.	There	were	also	differences	between	the	 imputation	strategies	524	
used	by	the	two	studies;	whereas	in	Locke	et	al.[8]	SNPs	were	imputed	to	HapMap	2	reference	panel,	525	
our	dataset	was	 imputed	 to	 the	1000	Genomes	reference	panel.	These	and	other	 factors	may	 impact	526	
the	association	of	the	lead	SNP	from	Locke	et	al.[8]	with	OTUs	in	this	dataset.	527	
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Our	heritability	and	host	genetic	association	results	show	that	human	genetic	factors	have	a	role	both	in	528	
determining	 obesity	 and	 in	 influencing	 the	 host	 fecal	microbial	 composition.	 The	 strong	 associations	529	
that	 we	 detect	 between	 fecal	 microbes	 and	 obesity	 phenotypes	 suggest	 that	 host	 genetics	 may	530	
influence	 these	 microbial-obesity	 associations.	 Using	 a	 candidate	 gene	 approach	 we	 identified	 host	531	
genetic	 variants	 in	 three	 obesity	 human	 loci,	which	 show	 associations	with	 adiposity-associated	 fecal	532	
microbes	in	our	dataset.	These	variants	are	promising	candidates	for	further	follow	up	studies	to	assess	533	
their	potential	role	in	obesity-microbial	interactions.	Although	human	obesity	is	highly	heritable,	human	534	
genetic	variants	detected	to	date	explain	only	a	small	proportion	of	the	heritability	in	obesity.	Given	our	535	
observation	that	the	average	microbial	heritability	is	greater	at	the	most	associated	adiposity-OTUs,	our	536	
results	are	therefore	consistent	with	the	hypothesis	that	a	proportion	of	the	heritability	in	obesity	may	537	
be	explained	by	heritable	fecal	microbes.	538	
Limitations	and	Considerations	539	
Due	 to	 the	 cross-sectional	 and	 observational	 nature	 of	 the	 study	we	 are	 unable	 to	 determine	 causal	540	
relationships	 between	 the	 fecal	 microbiota,	 host	 genetics	 and	 visceral	 adiposity.	 Furthermore,	 to	541	
determine	more	robust	genetic	associations,	we	require	a	much	larger	sample	size	than	is	represented	542	
here.	Lack	of	metagenomic	data	limits	our	functional	interpretation	of	the	microbial	dysbiosis	observed	543	
in	 obesity,	 although	 predictions	 from	 PICRUSt	 do	 provide	 some	 interesting	 insights	 for	 further	544	
investigation.	 Some	 research	 has	 shown	 that	 in	 individuals	 that	 are	 dieting,	 there	 is	 an	 increase	 in	545	
Bacteroidetes	and	conversely,	individuals	that	are	over-eating	show	an	abundance	of	Firmicutes[55].	It	546	
is	therefore	important	to	know	whether	the	individuals	in	the	study	were	calorie	restricted	This	is	one	547	
limitation	of	the	present	study	and	future	work	should	focus	specifically	on	how	the	interaction	of	diet	548	
affects	visceral	 fat	associations	with	 the	 fecal	microbiome.	Other	considerations	 that	 should	be	 taken	549	
into	account	in	the	future	are	stool	consistency[73],	antibiotic	and	other	drug	use[74,	75].	550	
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Due	to	the	novelty	of	visceral	fat	measurement,	and	lack	of	adiposity	measurements	other	than	BMI	in	551	
other	microbiome	datasets,	we	lacked	true	replication	in	independent	cohorts	which	would	likely	have	552	
improved	 our	 results	 as	 would	 have	 having	 a	 better	 balance	 of	 genders	 in	 discovery	 and	 replication	553	
samples.		554	
Conclusion	555	
We	have	 found	strong	associations	between	 fecal	microbial	profiles	with	 total	and	visceral	 fat,	 in	 the	556	
largest	 fecal	 microbiota-obesity	 study	 to	 date	 using	multiple	measures	 of	 human	 adiposity,	 some	 of	557	
which	 are	 robustly	 replicated.	 We	 identify	 novel	 and	 confirm	 previously	 established	 fecal	 microbe	558	
associations	with	overall	obesity,	and	additionally,	our	study	can	also	help	distinguish	protective	and	risk	559	
microbes	 in	human	cardiovascular	and	metabolic	disease	 risk,	by	using	visceral	 fat	as	 risk	phenotype.	560	
We	 obtain	 novel	 high	 heritability	 estimates	 for	 visceral	 fat	 and	 android:gynoid	 ratio	 in	 a	 large	 twin	561	
sample,	 and	 confirm	 previously	 reported	 heritability	 estimates	 for	 other	 adiposity	 measures.	562	
Furthermore,	we	 identify	promising	host	genetic	 variants	 that	may	 influence	 the	 interaction	between	563	
the	 human	 fecal	 microbiome	 and	 obesity	 and	 its	 metabolic	 consequences.	 Our	 findings	 support	 the	564	
hypothesis	 that	 heritable	 microbes	 play	 a	 major	 role	 in	 the	 components	 of	 adiposity	 that	 are	 most	565	
relevant	to	cardio-metabolic	disease	risk.		566	
	567	
Methods		568	
Subjects	and	sample	collection	569	
All	subjects	included	in	the	study	were	healthy	volunteers	from	the	TwinsUK	Adult	Twin	Registry[50,	76].	570	
Adiposity	phenotype	data	were	collected	on	the	extended	sample	of	3,666	twins	(Table	1).	These	571	
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included	1,044	monozygotic	(MZ)	and	789	dizygotic	(DZ)	predominantly	female	twin	pairs.	The	sample	572	
was	predominantly	of	European	descent	and	the	average	age	was	63	(Table	1).	Fecal	microbiome	data	573	
were	obtained	for	a	subset	of	1,313	individuals	from	the	sample	3,666	twins.	The	microbiome	dataset	574	
included	496	MZ,	594	DZ	and	223	unrelated	individuals,	who	were	also	predominantly	female,	575	
European,	and	the	average	age	was	also	63	(Table	1	and	Additional	File	4:	Supplementary	Table	7).	Fecal	576	
samples	from	all	individuals	followed	the	same	collection	protocol	as	previously	reported	[31,	33,	34].	577	
Briefly,	fecal	samples	were	refrigerated	or	kept	on	ice	for	1-2	days	prior	to	arriving	at	the	laboratory	at	578	
the	Department	for	Twin	Research,	King’s	College	London,	at	which	point	they	were	immediately	stored	579	
for	up	to	8	weeks	at	-80°C	before	DNA	extraction.	Frozen	samples	were	shipped	to	Cornell	University	for	580	
DNA	extraction,	PCR	amplification,	and	sequencing.	The	study	was	approved	by	the	local	research	ethics	581	
committee,	and	signed	and	written	consent	was	obtained	from	all	participants.	582	
Fecal	microbiome	profiles	583	
This	manuscript	explores	16S	gut	microbial	profiles	from	a	total	of	1,313	twin	stool	samples.	Of	these,	584	
601	 16S	 fecal	microbiome	 profiles	were	 previously	 described	 by	Goodrich	 et	 al[35],	 and	 671	 profiles	585	
were	 recently	 published	 in	 Jackson	 et	 al	 (2015)[34],	 and	 additional	 16S	 microbial	 profiles	 were	586	
generated	in	a	further	41	twin	stool	samples[33],	giving	us	altogether	1,313	individuals	for	whom	both	587	
16S	 gut	microbial	 data	 and	 adiposity	measures	 were	 available.	 The	 sequence	 data	 for	 the	 discovery	588	
TwinsUK	fecal	microbial	sequence	dataset	used	in	this	study	is	available	from	the	European	Nucleotide	589	
Archive	(ERP006339,	ERP006342,	ERP015317).	590	
	Briefly,	all	 samples	underwent	 the	same	 laboratory	protocol	and	data	processing	steps,	 following	the	591	
quality	control	procedure	outlined	by	Goodrich	et	al.	[35].	DNA	extracted	from	fecal	samples	underwent	592	
amplification	 of	 the	 V4	 region	 of	 the	 16S	 rRNA	 gene	 using	 the	 515F	 and	 806R	 primers,	 followed	 by	593	
250bp	 paired-end	 sequencing	 on	 the	 Illumina	 MiSeq	 platform.	 Processing	 of	 sequencing	 and	 OTU	594	
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picking	was	carried	out	as	previously	described[34].	In	brief,	paired-end	sequences	were	merged	with	at	595	
least	a	200bp	overlap,	and	 those	over	275bp	 in	 length	were	 filtered	 from	the	dataset.	The	 remaining	596	
sequences	 were	 analysed	 using	 QIIME	 1.7.0	 (Quantitative	 Insights	 Into	 Microbial	 Ecology)[45].	597	
Sequences	containing	ambiguous	or	 low	quality	 reads	 (Phred	score	≤	 25)	and	uncorrectable	barcodes	598	
were	 removed	 from	 the	 dataset	 and	 open-reference	 OTU	 picking	 was	 performed	 against	 the	599	
Greengenes	May	2013	database.	OTUs	not	found	in	at	least	25%	of	individuals	were	then	discarded	and	600	
their	 counts	 were	 converted	 to	 relative	 abundances	 within	 samples,	 followed	 by	 the	 addition	 of	 a	601	
pseudocount	(10-6)	to	remove	zero	counts.	 	Mixed	effects	models	were	fitted	to	these	data	to	control	602	
for	 technical	and	batch	effects.	The	 regression	 included	sequencing	 run,	depth	of	 sample	sequencing,	603	
and	technician	who	extracted	and	loaded	the	DNA	for	sequencing,	as	well	as	sample	collection	method	604	
(by	post	or	in	person)	as	predictors	with	OTU	abundances	as	the	response.	Residuals	from	these	models	605	
were	 then	 used	 in	 subsequent	 downstream	 analyses.	 The	 adiposity-OTU	 and	 OTU	 candidate	 gene	606	
downstream	analyses	also	included	further	adjustment	for	covariates	such	as	age,	gender,	and	five	long-607	
term	 (10-year)	 summary	 broad	 dietary	 profiles	 (see	 phenotype	 Methods	 section).	 The	 final	 dataset	608	
contained	2,135	OTUs.	609	
In	estimating	collapsed	taxonomy	quantifications,	OTUs	from	the	complete	set	(including	those	in	<25%	610	
of	 individuals)	were	 collapsed	 into	 genera	 and	 families	 based	 on	 shared	 taxonomic	 assignment.	 Taxa	611	
found	 in	 fewer	 than	 10	 individuals	 were	 then	 discarded	 and	 the	 counts	 converted	 to	 relative	612	
abundances.	 We	 applied	 the	 OTU	 quality	 control	 regression	 framework	 to	 correct	 for	 technical	613	
covariates	and	batch	effects	 as	described	above,	 and	 then	used	 the	 resulting	 residuals	 in	 subsequent	614	
downstream	analyses.	615	
Phenotype	data	616	
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Obesity	 phenotype	 data	 were	 collected	 during	 each	 participant’s	 annual	 clinic	 visit.	 We	 explored	 6	617	
obesity	 related	 phenotypes	 in	 this	 work	 for	 a	 complete	 dataset	 of	 3,666	 phenotyped	 twins.	 The	618	
adiposity	 phenotypes	 included	 a	 number	 of	 measures	 from	 total	 body	 DXA	 (Dual-Energy	 X-ray	619	
Absorptiometry)	whole-body	scanning.	During	the	DXA	procedure	participants	were	asked	to	lie	flat	and	620	
straight	while	 a	 full	 body	 scan	 took	place,	 as	previously	 reported[77]	 taking	measures	 for	percentage	621	
trunk	 fat	and	visceral	 fat	mass	 (g)[32].	Visceral	 fat	mass	was	calculated	 from	one	cross-section	of	 the	622	
whole	body	at	L4-L5,	the	typical	location	of	a	CT	slice.	Other	phenotypes	collected	were	subcutaneous	623	
fat	mass,	 percentage	 trunk	 fat,	BMI,	 android:gynoid	 ratio	 and	waist:hip	 ratio.	 Subjects	were	asked	 to	624	
remove	their	shoes	and	height	(cm)	was	measured	using	a	stadiometer.	Weight	(kg)	was	measured	on	625	
digital	 scales.	Waist	 circumference	was	measured	using	a	 tape,	halfway	between	 the	 lower	border	of	626	
the	ribs	and	the	 iliac	crest	 in	a	horizontal	plane.	Hip	circumference	was	measured	at	the	widest	point	627	
over	the	buttocks.	628	
Covariates	for	phenotypic	analyses	included	age	and	gender	in	all	3,666	individuals	and	dietary	profiles	629	
in	1,313	individuals.	We	did	not	have	detailed	dietary	information	at	the	time	of	fecal	sample	donation	630	
for	 this	 dataset,	 however	 we	 had	 available	 previously	 collected	 and	 reported	 dietary	 profiles	 [78].		631	
Teucher	et	al.	collected	food	frequency	questionnaires	and	performed	principal	component	analysis	on	632	
these	data.	 The	proportion	of	 variance	explained	by	 the	 first	 five	principal	 components	was	22%	and	633	
they	corresponded	broadly	to	the	following	approximate	diets:	Fruit	and	Veg,	Traditional	English,	High	634	
Alcohol,	 Dieting	 and	 Low	Meat	 (see	 [78]).	 We	 used	 these	 five	 variables	 as	 long-term	 stable	 dietary	635	
profiles	in	the	downstream	microbiome	association	analyses.	636	
Statistical	Analysis		637	
To	assess	the	evidence	for	association	between	fecal	microbiome	composition	and	obesity-related	and	638	
metabolic	phenotypes,	we	performed	two	principal	analyses.	First,	we	compared	microbiome	OTUs	and	639	
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phenotypes	by	fitting	a	linear	mixed	effects	model	(LMER)	using	the	R	package	lme4[79]	across	all	1,313	640	
individuals.	 In	 this	 model	 the	 phenotype	 was	 the	 response	 variable	 and	 the	 OTU	 was	 a	 fixed	 effect	641	
predictor.	Additional	factors	included	family	and	zygosity	taken	into	account	as	random	effects,	and	sex,	642	
age,	 and	 dietary	 profiles	 (principle	 components)	 considered	 as	 fixed	 effects.	 Each	 phenotype	 was	643	
normalised	 to	 a	 standard	 Normal	 distribution	 prior	 to	 analysis.	 To	 assess	 the	 significance	 of	 the	644	
associations,	we	compared	the	full	regression	model	described	above,	to	a	null	model	that	excluded	the	645	
OTU	 predictor	 using	 an	 analysis	 of	 variance	 (ANOVA)	 test	 in	 R.	 We	 report	 associations	 that	 passed	646	
nominal	significance	(P	=	0.05),	as	well	as	those	that	passed	a	Bonferroni	threshold	for	multiple	testing	647	
(P	=	3.90x10-06)	648	
Heritability,	the	proportion	of	total	variance	in	a	trait	attributed	to	genetics,	was	assessed	using	the	ACE	649	
model.	Under	 the	assumption	 that	 the	dominance	effects	are	negligible,	 the	ACE	model	 can	estimate	650	
the	additive	genetic	(A),	common	environment	(C)	and	unique	environment	(E)	components	of	the	trait	651	
variance.	 Narrow-sense	 heritabilities	 were	 estimated	 from	 the	 proportion	 of	 the	 total	 phenotypic	652	
variance	explained	by	estimated	additive	genetic	effect.	 To	estimate	parameters	of	 the	ACE	model,	 a	653	
maximum-likelihood	 method	 was	 applied	 under	 multivariate	 normality	 assumptions	 using	 OpenMx	654	
software[80],	a	structural	equation	modelling	package	 in	R.	We	also	provide	95%	confidence	 intervals	655	
for	both	phenotype	and	OTU	heritability	estimates	in	this	study.	656	
Functional	analysis	was	performed	using	PICRUST	v1.0.0.	Counts	of	KEGG	functions	were	obtained	then	657	
transformed	 into	 relative	 abundances.	 The	 values	 were	 then	 transformed	 using	 the	 Hellinger	658	
transformation	 prior	 to	 adjustment	 for	 the	 following	 technical	 covariates:	 sequencing	 run,	 technician	659	
who	performed	the	DNA	extraction	and	technician	who	loaded	the	plate.	The	functional	residuals	from	660	
this	 adjustment	 were	 then	 fit	 into	 a	 linear	 mixed	 effects	 regression	 as	 predictor	 variables,	 where	661	
adiposity	phenotypes	were	the	response.	Further	covariates	in	the	regression	included	age,	sex,	zygosity	662	
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and	 family	 structure	 as	 described	 above.	 Differential	 abundance	 analysis	 was	 performed	 on	 the	663	
residuals	 using	 STAMP[47]	whereby	 a	 two-sided	Welch’s	 t-test	was	used	 to	 test	 the	difference	 in	 KO	664	
counts	between	high	and	low	visceral	fat	groups.	Benjamini-Hochberg	FDR	correction[81]	was	applied	to	665	
the	 association	 p-values	 from	 the	 linear	 mixed	 effects	 regression	 and	 the	 differential	 abundance	666	
analysis.	667	
Host	Genomic	Analyses	668	
Host	genotype	data	were	available	in	1,059	individuals	from	the	microbiome	dataset	(see	Additional	File	669	
5).	 Briefly,	 genotyping	 in	 TwinsUK	 was	 performed	 with	 a	 combination	 of	 Illumina	 HumanHap300,	670	
HumanHap610Q,	 1M-Duo	 and	 1.2MDuo	 1M	 chips,	 and	 genotypes	 were	 called	 as	 previously	671	
described[50].	 Imputation	 was	 performed	 using	 the	 IMPUTE	 software	 package	 (v2)[82]using	 as	672	
reference	 panel	 the	 1,000	 Genomes	 haplotypes	 (based	 on	 SHAPEIT2)	 Phase	 I	 integrated	 variant	 set	673	
release	(v3)	(September	2013)	(see	Additional	File	5	for	further	details).	674	
In	the	candidate	gene	analysis	the	list	of	human	candidate	obesity	GWAS	SNP	associations	was	obtained	675	
from	Locke	et	al.[8].	The	reported	SNPs	in	Locke	et	al.	were	taken	as	the	lead	SNP	and	candidate	gene	676	
regions	were	extended	to	include	additional	SNPs	within	a	25	kb	region	either	side	of	the	lead	SNP.	SNPs	677	
were	included	in	downstream	analysis	if	they	had	a	MAF	of	5%	and	an	info	score	of	more	than	0.4	in	our	678	
imputed	sample.	Overall,	there	were	8,876	SNPs	across	97	unique	genomic	regions	that	were	included	679	
in	downstream	association	analyses.	Host	genetic	association	analysis	was	performed	using	the	software	680	
GEMMA	(Genome-wide	Efficient	Mixed	Model	Association)[83]	at	the	variants	included	in	the	97	human	681	
obesity	 candidate	 loci.	 GEMMA	 implements	 a	 univariate	 linear	 mixed	 model	 to	 perform	 association	682	
tests,	using	a	kinship	matrix	to	take	into	account	twin	relatedness.		683	
	 32	
DNA	 methylation	 profiles	 were	 obtained	 in	 542	 female	 Caucasian	 twins	 using	 the	 Infinium	684	
HumanMethylation450	BeadChip	assay	(Illumina	450k).	The	DNA	methylation	Illumina	450k	dataset	was	685	
obtained	from	adipose	tissue	biopsies	in	the	twins,	as	previously	described[50]	(ArrayExpress	E-MTAB-686	
1866).	 	 DNA	 methylation	 levels	 were	 first	 normalized	 using	 BMIQ[84],	 and	 adjusted	 for	 covariates	687	
including	age,	smoking,	alcohol,	zygosity,	family,	plate,	bisulphite-sequencing	(BS)	conversion	efficiency,	688	
and	BS	 conversion	 concentration	 (see	Additional	 File	 5).	 The	 resulting	 residuals	were	 normalized	 and	689	
methylation	 QTL	 analysis	 was	 performed	 using	 Matrix	 eQTL[85].	 The	 analysis	 considered	 genetic	690	
association	under	 the	additive	model	between	genetic	 variants	 at	 rs74331972,	 rs1433723,	 rs2480677	691	
and	467,928	DNA	methylation	probes	that	passed	quality	control.	692	
Gene	 expression	 Quantitative	 Trait	 Locus	 (eQTL)	 results	 were	 available	 from	 a	 large-scale	 study	 of	693	
human	gene	expression	in	multiple	tissue	samples	including	subcutaneous	fat,	lymphoblastoid	cell	lines	694	
and	whole	skin,	derived	from	856	monozygotic	(MZ)	and	dizygotic	(DZ)	female	twins	from	the	TwinsUK	695	
cohort,	 as	 part	 of	 the	MuTHER	 project[49].	We	 interrogated	 the	 candidate	 SNPs	 for	 eQTL	 results	 in	696	
adipose	 tissue	 (subcutaneous	 fat)	 using	 the	 Genevar	 software[86].	 The	 functional	 impact	 of	 the	697	
candidate	SNPs	was	also	explored	using	GTEx	results	across	multiple	tissues,	using	GTEx	Analysis	Release	698	
V6		(dbGaP	Accession	phs000424.v6.p1)[48].	699	
Replication	of	obesity-microbial	associations	in	independent	cohorts	700	
American	Gut	Cohort	701	
Replication	analyses	were	pursued	in	2,338	individuals	from	the	American	Gut	project	(see	Additional	702	
File	5).	American	Gut	(AG)	participants	were	selected	from	sequence	rounds	1-21	(EBI:	ERP012803)	as	703	
Caucasian	over	the	age	of	20	with	a	BMI	between	18.5	and	30,	and	living	in	the	US,	UK,	Australia	or	704	
Canada	(Additional	File	4:	Supplementary	Table	7).	Sequencing	protocols	of	the	American	Gut	samples	705	
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have	previously	been	described[62,	87,	88].	Additionally,	the	fecal	sample	had	to	have	at	least	1,000	706	
sequences	when	picked	closed	reference	using	SortMeRNA[89]	against	the	August	2013	release	of	707	
Greengenes[90].	American	Gut	samples	were	pre-processed	to	remove	candidate	overgrowth	708	
sequences,	as	described	elsewhere[91].	OTUs	were	picked	using	closed	reference	in	QIIME[45]	at	97%	709	
using	UCLUST[46]	against	the	97	replication	OTUs,	and	96	OTUs	were	successfully	identified.	Regression	710	
was	performed	in	Statsmodels[92]	using	a	three-step	model.	OTUs	were	power	transformed	and	offset	711	
by	1.	The	power	transform	was	regressed	to	control	for	technical	covariates	(see	Additional	File	5).	712	
Residuals	from	this	were	regressed	against	lifestyle	covariates,	including	age,	last	antibiotic	use,	IBD	713	
diagnosis,	flossing	frequency	and	country.	Normalized	BMI	was	regressed	against	the	residual	from	the	714	
second	regression,	with	sex	as	a	covariate.	In	the	AG	BMI-OTU	association	results	we	observed	that	26	715	
associations	had	the	same	direction	of	effect	while	18	were	nominally	significant	and	had	the	same	716	
direction	effect	as	the	TwinsUK	discovery	sample.	717	
FGFP	Cohort	718	
Replication	analyses	were	pursued	in	917	individuals	from	the	Belgian	Flemish	Gut	Flora	Project	(FGFP)	719	
(see	Additional	File	5),	selected	as	Caucasians	over	the	age	of	20	with	a	BMI	between	18.5	and	30	[17].	720	
Prior	to	OTU	picking,	sequencing	depth	was	downsized	to	10000	reads	per	sample.	OTUs	were	picked	in	721	
QIIME[45]	at	97%	using	UCLUST[46]	by	closed	reference	picking	against	the	97	replication	OTUs,	and	96	722	
OTUs	were	successfully	detected	in	FGFP.	OTU	abundances	were	power	transformed	and	offset	by	1.	723	
The	power	transform	was	regressed	to	control	for	age,	gender,	alcohol	average	consumption	in	the	724	
week	prior	to	sampling	and	smoking(yes/no).	Normalized	BMI	was	then	regressed	against	the	residual	725	
from	the	first	regression,	with	gender,	dietary	restrictions	(None/Vegetarian,Vegan,Macrobiotic/Other)	726	
as	covariates.		727	
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In	the	FGFP	BMI-OTU	association	results	we	observed	that	83	associations	had	the	same	direction	of	728	
effect	while	34	were	nominally	significant	and	had	the	same	direction	effect	as	the	TwinsUK	discovery	729	
sample.	730	
TwinsUK	Replication	Dataset	731	
The	extended	TwinsUK	fecal	microbiome	dataset	was	recently	described	[33],	and	included	a	set	of	732	
1,031	individuals	(not	overlapping	with	the	1,313	TwinsUK	discovery	sample	here)	for	whom	both	fecal	733	
microbial	profiles	and	BMI,	but	not	visceral	fat,	were	available.	We	therefore	included	these	additional	734	
data	as	a	third	replication	sample	(TwinsUK	(TUK-R)),	where	all	individuals	were	of	European	descent	735	
over	the	age	of	20	with	a	BMI	between	18.5	and	30.	Read	data	was	closed-reference	clustered	using	the	736	
representative	sequences	for	the	replication	OTUs	as	a	reference,	using	UCLUST[46]	at	97%	in	QIIME	737	
v1.9.0[45].	Counts	for	each	OTU	in	each	individual	were	converted	to	relative	abundances	by	dividing	by	738	
the	total	number	of	reads	in	the	sample.	A	count	of	0.000001	was	added	to	the	relative	abundances	to	739	
account	for	zeros	and	these	were	then	log	transformed.	The	transformed	counts	were	then	residualised	740	
to	adjust	for	sequencing	run,	collection	method,	person	who	loaded	the	plate	and	person	who	741	
performed	the	DNA	extraction.	Lifestyle	covariates	included	in	downstream	analyses	matched	those	742	
described	for	the	TwinsUK	discovery	sample.	Altogether,	76	associations	showed	the	same	direction	of	743	
effect	and	7	associations	were	nominally	significant	in	the	TwinsUK	replication	sample.	744	
	745	
Meta-analysis	across	cohorts		746	
Random-effects	meta-analysis	was	first	performed	across	the	three	replication	samples	(American	Gut,	747	
FGFP,	and	TwinsUK	replication).	We	considered	OTU-BMI	results	to	replicate	if	they	showed	the	same	748	
direction	of	association	with	BMI	in	the	meta-analysis	as	in	the	discovery	TwinsUK	sample,	and	if	the	749	
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significance	level	in	the	meta-analysis	passed	Bonferroni	adjustment	for	multiple	testing	(P	=	5.15x10-4).	750	
We	also	performed	a	meta-analysis	across	all	four	population	samples,	to	identify	additional	OTUs	at	751	
which	the	evidence	for	association	with	BMI	improved	over	the	discovery	TwinsUK	P-value,	even	if	these	752	
did	not	reach	the	Bonferroni	significance	cut-off	for	replication.		In	each	meta-analysis,	we	assessed	753	
evidence	for	heterogeneity	using	Cochran’s	Q-statistic	and	the	I2-statistic[93],	and	only	considered	754	
results	with	no	strong	evidence	for	heterogeneity	(Cochran’s	Q	P>0.05	and	I2<0.75).	The	meta-analysis	755	
was	performed	in	R	3.1.2	using	the	R	package	‘metafor’[94]	using	as	input	beta	coefficients	and	756	
standard	errors	from	each	independent	cohort.		757	
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Figure	Legends	
Figure	1.	Distribution	and	heritability	of	adiposity	phenotypes.	A)	Scatterplot	matrix	showing	the	
distribution	and	correlation	between	six	adiposity	measures	in	3,666	twins.	The	distribution	of	
each	phenotype	(prior	to	normalisation)	is	shown	along	the	diagonal.	The	lower	panel	shows	
scatterplots	for	each	pair	of	adiposity	phenotypes	and	the	upper	panel	denotes	the	coefficients	of	
determination.	B)	Heritability	of	six	adiposity	measures	in	the	TwinsUK	cohort,	as	well	as	visceral	
fat	measures	in	3	independent	cohorts:	Framingham[40],	Quebec[42]	and	Heritage[41].	The	total	
variance	of	each	adiposity	phenotype	is	decomposed	into	variance	components	attributed	to	
additive	genetics	(A)	or	narrow-sense	heritability	(h2),	common	environment	(C)	and	unique	
environment	(E).	
	
Figure	2.	Alpha	diversity	of	the	fecal	microbiome	in	individuals	with	high	and	low	fat	content.	
For	each	phenotype,	individuals	who	were	more	than	1.5	standard	deviations	from	the	mean	of	
the	phenotype	were	assigned	to	high	and	low	phenotype	groups	respectively.	Alpha	diversity	
measures	(using	Shannon	diversity)	were	compared	between	the	high	and	low	phenotype	groups	
(Wilcoxon	test	*	=	0.05	**	=	0.001	***	=	0.0001).		
	
Figure	3.	Associations	between	fecal	microbiome	16S	OTUs	and	visceral	fat	in	the	TwinsUK	
and	replication	datasets.	A)	The	inner	circle	denotes	the	phylogenetic	tree	of	OTUs,	produced	
using	iTOL[95]	based	on	GreenGenes	May	2013	tree	filtered	for	the	OTUs	in	the	sample.	Tree	
leaves	are	coloured	according	to	the	direction	of	association	with	visceral	fat,	where	blue	
indicates	a	negative	association,	while	red	indicates	a	positive	association.	The	outer	circle	
denotes	the	significance	of	each	OTU	-	visceral	fat	association,	where	P	values	are	plotted	as	–
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log10	(P	value)	and	the	red	line	shows	the	Bonferroni	significance	threshold.	The	figure	
highlights	the	most-associated	OTU	in	the	sample	(OTU	372146),	as	well	as	the	two	closed-
reference	OTUs	that	were	significantly	associated	with	host	genetic	variants	in	genes	FHIT	
(OTU	181702)	and	ELAVL4	(194733).	In	addition	it	also	highlights	the	heritable	
Christensenellaceae	OTU	176318.	The	figure	also	denotes	the	tree	branches	containing	
members	of	the	Clostridiales,	Bacteroides,	and	Christensenellaceae	to	accompany	results	and	
discussion	in	the	main	text.	B)	Forest	plot	of	beta	coefficients	with	confidence	intervals	of	8	
OTUs	that	replicated	robustly	in	a	meta-analysis	of	3	independent	cohorts	(TUK-R,	AG	&	
FGFP).	
	
Figure	4.	Microbial	functional	analysis	in	obesity.	A)	Microbial	PICRUSt-predicted	KEGG	functions	
relevant	to	metabolism	in	the	twin	dataset,	and	their	association	with	the	six	adiposity	measures.	
The	heatmap	denotes	the	direction	of	association	between	each	microbial	PICRUSt-predicted	
KEGG	function	and	adiposity	measures,	where	blue	indicates	a	negative	association,	while	red	
indicates	a	positive	association.	Bonferroni-significant	associations	are	highlighted	(*).	B)	Five	KO	
genes	that	are	differentially	abundant	between	high	and	low	visceral	fat	individuals	in	glyoxylate	
and	dicarboxylate	metabolism,	as	tested	by	a	two-sided	Welch’s	t-test.	FDR-adjusted	p-values	are	
reported	at	the	right	of	the	image	and	stars	indicate	Bonferroni-significant	associations.	Figure	was	
produced	using	STAMP[47].		
	
Figure	5.	Peak	genetic	associations	between	obesity	human	genetic	variants	and	adiposity-
associated	OTUs	in	the	twin	fecal	microbiome.	A)	Association	between	OTU	181702	and	FHIT	SNP	
rs74331972.	The	boxplot	indicates	change	in	OTU	181702	abundance	with	genotype	at	SNP	
rs74331972.	The	LocusZoom	plot	denotes	the	strength	of	association	of	OTU	181702	with	SNP	
rs74331972,	as	well	as	the	SNPs	in	the	surrounding	region.		B)	Association	between	open	
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reference	OTU	25576	and	TDRG1	SNP	rs1433723.	The	boxplot	indicates	change	in	open	reference	
OTU	25576	abundance	with	genotype	at	SNP	rs1433723.	The	LocusZoom	plot	denotes	the	
strength	of	association	of	open	reference	OTU	25576	with	SNP	rs1433723,	as	well	as	the	SNPs	in	
the	surrounding	region.		C)	Association	between	OTU	194733	and	ELAVL4	SNP	rs2480677.	The	
boxplot	indicates	change	in	OTU	194733	abundance	with	genotype	at	SNP	rs2480677.	The	
LocusZoom	plot	denotes	the	strength	of	association	of	OTU	194733	with	SNP	rs2480677,	as	well	as	
the	SNPs	in	the	surrounding	region.	SNPs	in	all	LocusZoom	plots	are	coloured	according	to	their	
strength	of	LD	with	the	peak	SNP	plotted.		
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Tables	
Table	1.	Description	of	the	TwinsUK	discovery	sample.		
	 Full	Dataseta	 Microbiome	Subsetb	
No	of	Samples	 3666	 1313	
Sex	 	 	
Female	 3296	 1266	
Male	 370	 47	
Zygosity	 	 	
MZ	 2088	 496	
DZ	 1578	 594	
Unrelated	 0	 223	
Age	(mean	(range))	 63	(32	-	87)	 63	(32	-	87)	
BMI	(mean	(range))	 26.1	(15.7	-	49.9)	 26.1	(16.2	-	45.9)	
Ethnicity	 	 	
European	 3511	 1295	
Other	 102	 9	
Unknown	 53	 8	
	
a	Summaries	are	shown	for	both	the	extended	dataset	of	3,666	twins	used	in	the	phenotype	
heritability	analyses,	and	for	the	microbiome	sample	subset	of	1,313	individuals.	b	Additional	File	
4:	Supplementary	Table	7	includes	extended	descriptions	of	the	microbiome	data	subset.		
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Additional	Files	
Additional	File	1:	Genus-level	heritability	estimates	between	the	TUK	discovery	dataset	and	
Goodrich.	A)	Scatterplot	showing	the	genus-level	heritability	between	TUK-D	and	Goodrich	et	al	
(2014)[2]	(r2	=	0.67).	B)	Scatterplot	showing	the	genus-level	heritability	between	TUK-D	and	
Goodrich	et	al	(2016)	(r2	=	0.76).	(PDF)		
Additional	File	2:	Comparison	of	alpha	diversity	and	human	adiposity	phenotypes.	Alpha	diversity	
is	measured	using	the	Shannon	metric.	For	each	adiposity	phenotype	considered	in	this	study	we	
present	the	R2	and	strength	of	association,	and	a	trend	line	is	shown	in	red.	(PDF)	
Additional	File	3:	Concordance	of	OTU-BMI	association	results	at	the	97	OTUs	between	TwinsUK	
discovery	sample	and	the	three	independent	replication	cohorts.	Points	marked	in	red	show	no	
consistent	effect	between	the	studies	while	blue	denotes	consistent	direction	of	association.	Blue	
points	that	are	empty	circles	are	not	significant,	while	blue	filled	circles	indicate	nominally	
significant	results.		A)	Scatterplot	between	TwinsUK	discovery	sample	(TUK-D)	and	American	Gut	
(AG).	B)	Scatterplot	between	TUK-D	and	FGFP.	C)	Scatterplot	between	TUK-D	and	TwinsUK	
replication	sample	(TUK-R).	(PDF)	
Additional	File	4:	Supplementary	Tables.	Supplementary	Table	1:	OTUs	showing	at	least	moderate	
(A	>0.2)	heritability	in	the	extended	TwinsUK	16S	dataset.	Each	variance	component,	additive	
genetics	(A,	or	heritability),	shared	environment	(C)	and	unique	environment	(E)	are	shown	along	
with	with	upper	and	lower	95%	confidence	intervals.	Average	relative	abundance	of	the	OTUs	in	
the	overall	dataset	is	also	shown.		Supplementary	Table	2:	149	Bonferonni-significant	OTU-
adiposity	associations.	OTU-adiposity	results	are	obtained	from	linear	mixed	effects	regression	
models,	and	include	the	original	results	(OTU-Adiposity)	and	results	after	adjustment	for	BMI	
(OTU-Adiposity	BMI-adjusted).	We	also	provide	the	OTU	heritability	and	average	OTU	abundance	
in	the	cohort.	The	last	two	columns	show	the	OTU	results	from	the	within	MZ	twin-pair	difference	
analyses	(MZ	Diff	Beta),	and	whether	the	MZ	results	were	concordant	with	the	linear	mixed	effects	
results.	Reported	phenotypes	are	visceral	fat	(VFM),	subcutaneous	fat	(SFM),	android:gynoid	ratio	
(AGR),	BMI,	waist:hip	ratio	(WHR)	and	%	trunk	fat	(pTF).	Supplementary	Table	3.	Genus-level	
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associations	with	adiposity,	where	the	collapsed	taxonomy	OTU	genus	was	significantly	associated	
with	adiposity.	Reported	phenotypes	are	visceral	fat	(VFM),	subcutaneous	fat	(SFM),	
android:gynoid	ratio	(AGR),	and	BMI.	Supplementary	Table	4:	Replication	of	TwinsUK	(TUK-D)	
results	in	3	independent	cohorts,	the	American	Gut	(AG),	the	Flemish	Gut	Flora	Project	(FGFP)	and	
the	expanded	TwinsUK	dataset	(TUK-R).	The	Table	lists	the	97	OTUs	forming	149	significant	
adiposity	associations	in	TwinsUK,	and	their	association	with	BMI	in	both	the	replication	and	
discovery	samples.	In	addition	the	table	outlines	the	results	of	two	meta-analyses	that	were	
performed	across	the	studies,	the	first	of	just	the	independent	cohorts,	and	the	second	including	
the	discovery	cohort.	Finally,	the	last	section	of	the	table	shows	which	OTUs	were	replicated	in	at	
least	one	of	the	replication	cohorts.	Supplementary	Table	5:	Human	genomic	analyses	at	
adiposity-related	candidate	host	genes	FHIT,	TDRG1	and	ELAVL4.	The	table	shows	significant	
genetic	associations	between	the	adiposity-related	candidate	host	genetic	variants	and	adiposity-
associated	OTUs.	The	final	three	columns	summarize	the	results	of	the	association	between	the	
host	genetic	variants	and	DNA	methylation	at	CpG	sites	targetted	by	the	Illumina	450K	array.	DNA	
methylation	association	was	performed	at	the	lead	OTU-associated	SNP	in	each	locus,	therefore	
rs1433722	was	not	tested	(NA).	Supplementary	Table	6:	List	of	the	97	BMI-associated	loci	
reported	in	Locke	et	al.	(2015)	that	were	used	for	analysis	in	this	study.	The	last	column	denotes	
the	BMI		GWAS	p-values	from	Locke	et	al.	(2015).	Supplementary	Table	7:	Demographics	of	the	
TwinsUK	microbiome	discovery	sample	and	the	American	Gut	replication	sample.	Supplementary	
Table	8:	ENA	accession	IDs	for	samples	in	this	study	currently	available	online	and	basic	metadata.	
(XLSX)	
Additional	File	5:	Supplementary	methods	including	expanded	methods	for	analyses	and	data	
collection	performed	within	the	discovery	cohort.	(DOCX)	
	
